Pictet Asset Management Sa Paratek Pharmaceuticals, Inc. Transaction History

Pictet Asset Management Sa

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$1.73 - $3.09 $96,111 - $171,668	55,556 Added 13.03%	481,827 $930,000
Q1 2022 May 13, 2022	BUY	$2.94 - $4.77 $268,207 - $435,152	91,227 Added 27.23%	426,271 $1.27 Million
Q4 2021 Feb 10, 2022	BUY	$4.07 - $5.3 $639,612 - $832,910	157,153 Added 88.34%	335,044 $1.5 Million
Q3 2021 Nov 12, 2021	BUY	$4.7 - $7.24 $836,087 - $1.29 Million	177,891 New	177,891 $865,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

Stay updated on Pictet Asset Management Sa with notifications on news.